Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings

被引:0
|
作者
Wyse, Jessica J. [1 ,2 ]
Eckhardt, Alison [1 ]
Newell, Summer [1 ]
Gordon, Adam J. [3 ,4 ,5 ]
Morasco, Benjamin J. [1 ,6 ]
Carlson, Kathleen [1 ,2 ]
Korthuis, P. Todd [2 ,7 ]
Ono, Sarah S. [1 ,6 ,8 ]
Lovejoy, Travis I. [1 ,6 ,8 ]
机构
[1] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
[2] OHSU PSU, Sch Publ Hlth, 1810 SW 5th Ave,Suite 510, Portland, OR 97201 USA
[3] VA Salt Lake City Hlth Care Syst, Analyt Sci IDEAS Ctr, Informat Decis Enhancement, 500 Foothill Dr, Salt Lake City, UT 84148 USA
[4] Univ Utah, Div Epidemiol, Sch Med, 295 Chipeta Way, Salt Lake City, UT 84132 USA
[5] Univ Utah, Dept Internal Med, Sch Med, 295 Chipeta Way, Salt Lake City, UT 84132 USA
[6] Oregon Hlth & Sci Univ, Dept Psychiat, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[7] Oregon Hlth & Sci Univ, Dept Med, Div Gen Internal Med & Geriatr, Sect Addict Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[8] Vet Rural Hlth Resource Ctr Portland, VA Off Rural Hlth, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
关键词
rural; veterans; access; opioid agonist; opioid use disorder; MEDICATION TREATMENT; BARRIERS; ACCESS; FACILITATORS; MODEL;
D O I
10.1007/s11606-024-08898-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundMedications for opioid use disorder (MOUD) including buprenorphine are effective, but underutilized. Rural patients experience pronounced disparities in access. To reach rural patients, the US Department of Veterans Affairs (VA) has sought to expand buprenorphine prescribing beyond specialty settings and into primary care.ObjectiveAlthough challenges remain, some rural VA health care systems have begun offering opioid use disorder (OUD) treatment with buprenorphine in primary care. We conducted interviews with clinicians, leaders, and staff within these systems to understand how this outcome had been achieved.DesignUsing administrative data from the VA Corporate Data Warehouse (CDW), we identified rural VA health care systems that had improved their rate of primary care-based buprenorphine prescribing over the period 2015-2020. We conducted qualitative interviews (n = 30) with staff involved in implementing or prescribing buprenorphine in these systems to understand the processes that had facilitated implementation.ParticipantsClinicians, staff, and leaders embedded within rural VA health care systems located in the Northwest, West, Midwest (2), South, and Northeast.ApproachQualitative interviews were analyzed using a mixed inductive/deductive approach.Key ResultsInterviews revealed the processes through which buprenorphine was integrated into primary care, as well as processes insufficient to enact change. Implementation was often initially catalyzed through a targeted hire. Champions then engaged clinicians and leaders one-on-one to "pitch" the case, describe concordance between buprenorphine prescribing and existing goals, and delineate the supportive role that they could provide. Sites were prepared for implementation by developing new clinical teams and redesigning clinical processes. Each of these processes was made possible with the active, instrumental support of leadership.ConclusionsResults suggest that rural systems seeking to improve buprenorphine accessibility in primary care may need to alter primary care structures to accommodate buprenorphine prescribing, whether through new hires, team development, or clinical redesign.
引用
收藏
页码:2142 / 2149
页数:8
相关论文
共 50 条
  • [31] Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care
    dela Cruz, Adriane M.
    Walker, Robrina
    Pipes, Ronny
    Wakhlu, Sidarth
    Trivedi, Madhukar H.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [32] Barriers and Facilitators to Expanding Buprenorphine Treatment for Opioid Use Disorder in Jail Settings
    Kelsch, Jordan
    McGladrey, Margaret
    Oser, Carrie
    Booty, Marisa
    Fanucchi, Laura
    Walsh, Sharon
    Lofwall, Michelle
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [33] Integrating Buprenorphine Into an Opioid Treatment Program: Tailoring Care for Patients With Opioid Use Disorders
    Polydorou, Soteri
    Ross, Stephen
    Coleman, Peter
    Duncan, Laura
    Roxas, Nichole
    Thomas, Anil
    Mendoza, Sonia
    Hansen, Helena
    PSYCHIATRIC SERVICES, 2017, 68 (03) : 295 - 298
  • [34] Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices
    Zittleman, Linda
    Curcija, Kristen
    Nease, Donald E., Jr.
    Fisher, Mary
    Dickinson, L. Miriam
    Thomas, John F.
    Espinoza, Ashley
    Sutter, Christin
    Ancona, Jennifer
    Holtrop, Jodi Summers
    Westfall, John M.
    ANNALS OF FAMILY MEDICINE, 2022, 20 (01) : 18 - 23
  • [35] Medication treatment for opioid use disorder among rural primary care patients
    Hser, Yih-Ing
    Zhu, Yuhui
    Baldwin, Laura-Mae
    Mooney, Larissa J.
    Saxon, Andrew J.
    JOURNAL OF RURAL HEALTH, 2024, 40 (01): : 195 - 199
  • [36] Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings
    Pham, Huyen
    Ober, Allison
    Baldwin, Laura-Mae
    Mooney, Larissa J.
    Zhu, Yuhui
    Fei, Zhe
    Hser, Yih-Ing
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (03) : 331 - 334
  • [37] Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings
    Frost, Madeline C.
    Soyer, Elena M.
    Achtmeyer, Carol E.
    Hawkins, Eric J.
    Glass, Joseph E.
    Hallgren, Kevin A.
    Williams, Emily C.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [38] Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings
    Madeline C. Frost
    Elena M. Soyer
    Carol E. Achtmeyer
    Eric J. Hawkins
    Joseph E. Glass
    Kevin A. Hallgren
    Emily C. Williams
    Addiction Science & Clinical Practice, 18
  • [39] Buprenorphine implant in opioid use disorder
    Martins, B.
    Agostinho, C.
    Aleixo, A.
    Martins, M.
    EUROPEAN PSYCHIATRY, 2018, 48 : S334 - S335
  • [40] Buprenorphine Therapy for Opioid Use Disorder
    Zoorob, Roger
    Kowalchuk, Alicia
    de Grubb, Maria Mejia
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (05) : 313 - 320